Summary Medlumics S.L. (Medlumics) is a medical equipment company that provides designs and develops integrated photonic devices by using advanced optical coherence tomography technology. The company provides its transformation of latest technological and scientific developments into innovative products in the field of biophotonics. It provides its services for design and manufacturing of optical coherence tomography (OCT) is a light based diagnostic technique. OCT is a noncontact, noninvasive imaging technique. Its techniques are used to obtain high resolution cross-sectional information of tissues. The company also offers OCT technique that finds its applications in the fields of ophthalmology, intravascular imaging in cardiology, dermatology and dentistry among others. Medlumics is headquartered in Tres Cantos, Madrid, Spain. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. Scope: - The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments - The report analyzes all pipeline products in development for the company Medlumics S.L. - The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status) - The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date - The report provides detailed description of products in development, technical specification and functions - The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date. Reasons To Buy: - Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape - Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio - To formulate effective Research & Development strategies - Develop market-entry and market expansion strategies - Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc - Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents 2 List of Tables 3 List of Figures 4 Medlumics S.L. Company Snapshot 5 Medlumics S.L. Company Overview 5 Medlumics S.L. Pipeline Products and Clinical Trials Overview 6 Medlumics S.L.- Pipeline Analysis Overview 8 Key Facts 8 Medlumics S.L. - Major Products and Services 9 Medlumics S.L. Pipeline Products by Development Stage 10 Medlumics S.L. Pipeline Products Overview 11 BiopsyPen 11 BiopsyPen Product Overview 11 Compact Microchip-Based OCT System 12 Compact Microchip-Based OCT System Product Overview 12 RF Ablation Catheter 13 RF Ablation Catheter Product Overview 13 Medlumics S.L. - Key Competitors 14 Medlumics S.L. - Key Employees 15 Medlumics S.L. - Locations And Subsidiaries 16 Head Office 16 Recent Developments 17 Medlumics S.L., Recent Developments 17 Sep 16, 2015: MedLumics Technology Validated for Real-time Assessment of Catheter Ablation Treatment of Atrial Fibrillation in Pre-clinical Feasibility Study 17 Oct 23, 2014: MedLumics Introduces NITID Skin Imaging System at EADV 17 Mar 25, 2014: MedLumics Announces BiopsyPen Project with €3.6M EU in Funding; Initiative Aimed at New Clinical Applications for Optical Coherence Tomography 18 Mar 25, 2014: MedLumics Announces BiopsyPen Project with €3.6M EU in Funding; Initiative Aimed at New Clinical Applications for Optical Coherence Tomography 18 Feb 01, 2014: MedLumics ISO 9001 Certification 19 Jan 22, 2014: MedLumics Expands Management Team in Preparation for 2014 Launch of First Generation Diagnostic Imaging System for Dermatology 19 Jul 22, 2013: MedLumics Appoints Dr. Wolfgang Reim as Independent Director 20 Aug 31, 2012: MedLumics Names Prof. Wolfgang Drexler President of its Scientific Advisory Board 20 Appendix 22 Methodology 22 About GlobalData 22 Contact Us 22 Disclaimer 22
List of Tables
Medlumics S.L. Pipeline Products and Clinical Trials Overview 6 Medlumics S.L. Pipeline Products by Equipment Type 6 Medlumics S.L. Pipeline Products by Indication 7 Medlumics S.L., Key Facts 8 Medlumics S.L., Major Products and Services 9 Medlumics S.L. Number of Pipeline Products by Development Stage 10 Medlumics S.L. Pipeline Products Summary by Development Stage 10 BiopsyPen - Product Status 11 BiopsyPen - Product Description 11 Compact Microchip-Based OCT System - Product Status 12 Compact Microchip-Based OCT System - Product Description 12 RF Ablation Catheter - Product Status 13 RF Ablation Catheter - Product Description 13 Medlumics S.L., Key Employees 15
List of Figures
Medlumics S.L. Pipeline Products by Equipment Type 7 Medlumics S.L. Pipeline Products by Development Stage 10
Global Bio polyethylene terephthalate (PET) market size is likely to be valued at USD 12.6 billion by 2020; as per a new research report by Radiant Insights, Inc. Growing preference of biopolymers in numerous applications coupled with favorable goverRead More...
Global automotive collision repair market is expected to be valued at USD 196.97 billion by 2020, as per a new research report by Radiant Insights, Inc. The industry is expected to witness significant growth owing to increasing number of on-road vehiRead More...
Global sorbitol market size is anticipated to be reach USD 3.99 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing consumer perception towards product benefits derived from natural ingredients is expected to drive the demRead More...
Global aerosol propellants market is anticipated to reach USD 24.8 billion by 2020, as per a new research report by Radiant Insights, Inc. Increasing popularity of personal care and cosmetics products such as hair sprays, deodorants and shaving creamRead More...
Global fingerprint access control systems market size is estimated to reach USD 4.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Growing safety and security concerns of individual as well as organization is projected to driRead More...
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Toll Free: 1-888-928-9744
Email: [email protected]
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.